Large-scale testing (Phase 3)Not Yet RecruitingNCT07544654
What this trial is testing
DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
Who this might be right for
Extrapulmonary Neuroendocrine Cancer
Boehringer Ingelheim 390